JAZZ

www.companiesandmarkets.com: Jazz Pharmaceuticals Inc - Corporate and Strategic Assessment Report - 10/07 - 10:47 AM ET

Jazz Pharmaceuticals Selects Service-now.com for On-Demand IT Service Management - 09/24 - 08:15 AM ET

Jazz Pharmaceuticals completes first Phase III study of fibromyalgia drug - 09/12 - 12:06 PM ET

JAZZ: Final Patient Completes Ph III Clinical Trial of JZP-6 for Fibromyalgia - 09/11 - 08:20 AM ET

Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia - 09/11 - 08:00 AM ET

Jazz Pharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results - 08/07 - 04:00 PM ET

JAZZ: Q2 Earnings Call @ 17:00 ET Today [delayed] - 08/07 - 02:24 PM ET

Jazz Pharmaceuticals Sets Date to Release Second Quarter Results - 07/31 - 02:53 AM ET

Jazz Pharmaceuticals, Inc. to Announce Second Quarter Results on August 7, 2008 - 07/24 - 05:00 PM ET

Jazz Pharmaceuticals Sells $26 Million Of Units - 07/22 - 04:30 AM ET

Jazz Pharmaceuticals Announces Closing of Registered Direct Offering - 07/21 - 05:00 PM ET

Jazz Pharmaceuticals Inc reports offering of common shares - 07/17 - 07:30 AM ET

Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering - 07/16 - 08:00 AM ET

JAZZ: Announces Filing of $100M Universal Shelf Registration - 06/12 - 08:10 AM ET

Jazz Pharma delays timelines for 2 programs, to cut 8% of work force - 06/11 - 05:18 PM ET

Jazz Pharmaceuticals Announces Development Timeline Updates - 06/11 - 04:55 PM ET

Jazz Pharmaceuticals Files Form S-3 Registration Statements - 06/11 - 04:50 PM ET

Jazz completes first Phase III trial enrollment for fibromyalgia treatment - 06/03 - 09:44 AM ET

JAZZ: Completes Enrollment for First Ph III Trial of JZP-6 for Fibromyalgia - 06/02 - 09:24 AM ET

JAZZ: To Present At UBS Global Pharmaceuticals Conference @ 04:30 ET [delayed] - 05/28 - 07:55 AM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index